| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 1.3K | 38.7% | 38.7% |
| Total Income | 1.3K | 36.7% | 40.9% |
| Expenditure | 1.1K | 29.6% | 28.0% |
| PBT | 178.56 | 108.3% | 288.8% |
| Net Profit | 145.11 | 95.2% | 365.9% |
| OPM | 18.70% | 4.40pp | 21.29pp |
| NPM | 11.08% | 3.32pp | 7.73pp |
| EPS | 16.09 | 95.3% | 366.4% |
Sharda Cropchem Q3 & 9M FY26: 4* Growth in Revenue, Highest-Ever Annual PAT, and Interim Dividend Declared
29 Jan 2026 · 29 Jan, 2:56 pm
Summary
Sharda Cropchem Ltd, a leading player in the crop protection chemicals industry, has announced its unaudited financial results for the quarter and nine months ended 31st December 2025. The company reported a 39% YoY increase in revenue to Rs. 1,289 crores in Q3 FY26, driven by volume and product mix. The Gross Profit Margin expanded by 220 basis points to 34.9% and EBITDA grew by 59% to Rs. 246 crores. The company has already achieved its highest-ever annual PAT of Rs. 362 crores in the first nine months of FY26.
Key Highlights
- 1
4* growth in revenue in Q3 FY26
- 2
Highest-ever annual PAT achieved in 9M FY26
- 3
Interim dividend of Rs. 6/- per equity share declared
- 4
Gross Profit Margin expanded by 220 basis points to 34.9% in Q3 FY26
- 5
EBITDA grew by 59% to Rs. 246 crores in Q3 FY26
- 6
Overall volumes increased by 14.4% Y-o-Y in Q3FY26
- 7
Agrochemical volumes grew by 20.1% & Non-Agrochemical volumes grew by 24.0% in 9MFY26
- 8
Capex in 9MFY26 stands at Rs. 399 crores
- 9
Product Registrations stand at 3,004 with 1,076 applications pending as on 31st December 2025
Management Comments
Mr. Ramprakash Bubna
Chairman and MD
In Q3 FY26, we delivered robust revenue growth of 39% YoY to Rs. 1,289 crores, mainly driven by a mix of volume and product mix. Europe has led as the key contributor in both volume and value terms. With input costs stabilizing, improving price dynamics and change in product mix, the Company’s Gross Margins has expanded by 220 basis points to 34.9% and we expect GP Margins to remain in a similar range going ahead. We expect prices to go up going forward. EBITDA has grown by 59% to Rs. 246 crores with EBITDA Margins at 19.1%, an increase of 250 basis points on Y-o-Y basis. For 9M FY26, revenues grew 29% to Rs. 3,203 crore with EBITDA increasing 64% to Rs. 527 crore. The Company has already achieved its highest-ever annual PAT within the first nine months of FY26 of Rs. 362 crores. The Company expects the growth momentum to continue in Q4 FY26 and remain strong in FY27.
Informational and educational content only. Not investment advice.